Secondary Logo

Editorial Board

​​​Editors
David A. Cooper
University of New South Wales,
Sydney, Australia
Giuseppe Pantaleo
University of Lausanne
Lausanne, Switzerland

Editorial Board

Marcus Altfeld
University of Hamburg,
Hamburg, Germany

Chris Beyrer
Johns Hopkins Bloomberg Scool of Public Health,
USA

Susan Buchbinder
San Francisco Department of Public Health,
San Francisco, USA

Steven Deeks
University of California,
San Francisco, USA

S Fidler
Imperial College London,
London, UK

​Beatriz Grinsztejn

Oswaldo Cruz Foundation - FIOCRUZ,
Rio de Janeiro, Brazil

Huldrych Gunthard
University Hospital Zurich,
Switzerland

Barton F. Haynes
Duke University Medical Center,
Durham, USA

Anthony Kelleher
University of New South Wales,
Sydney, Australia

Richard A. Koup
National Institutes of Health,
Bethesda, USA

Michael M. Lederman
Case Western Reserve University,
Cleveland, USA

Mathias Lichterfeld
Massachusetts General Hospital,
Harvard Medical School, USA

M. Juliana McElrath
University of Washington,
School of Medicine,
Seattle, USA

David C. Montefiori
Duke University Medical Center,
Durham, USA

Sarah Palmer
The University of Sydney,
Australia

Nittaya Phanuphak
Thai Red Cross AIDS Research Centre,
Bangkok, Thailand​

Peter Reiss
National AIDS Therapy Evaluation Center,
Amsterdam, The Netherlands

Douglas D. Richman
University of California San Diego,
San Diego, USA

Jurgen K. Rockstroh
University Hospital Bonn,
Bonn, Germany

N Russell
Bill & Melinda Gates Foundation,
Seattle, USA

C Sabin
University College London,
London, UK

RF Siliciano
Johns Hopkins University School of Medicine,
Baltimore, USA

G Silvestri
Emory University School of Medicine,
Atlanta, USA

GD Tomaras
Duke University Medical Center,
Durham, USA

Linqi Zhang
Tsinghua University,
Beijing, China


Sections

January
The PrEP revolution; from clinical trials to routine practice
Edited by Jared Baeten,
University of Washington,
Pennsylvania, USA
and Sheena McCormack,
MRC Clinical Trials Unit, London, UK

March
Immune Activation

Edited by Immune Activation,
National Institutes of Health, Maryland, USA  
and Marcus Altfeld, the Heinrich-Pette-Institute (HPI)

May
Bone complications in HIV

Edited by Patrick Mallon,
University College Dublin, Ireland
and Todd Brown, Johns Hopkins University,Maryland, USA

July
Strategies for targeting residual HIV infection
Edited by Nicolas Chomont,
Université de Montréal – CHUM Research Center,
Canada and Matthieu Perreau,
Lausanne University Hospital, Lausanne, Switzerland

September
Survival in the modern ART era
Edited by Margaret May,
University of Bristol and Dominique Costagliola,
Institut national de la santé et de la recherche médicale (INSERM), France

November
HIV Vaccine
Edited by Jerome Kim , International Vaccine Institute, USA and Stephen Kent University of Melbourne, Australia